Is the surge in cesarean section rates during the COVID-19 pandemic truly substantiated?

Piroozi, Bakhtiar; Moradi, Ghobad; Khoramipoor, Kimya; Mahmoodi, Hassan; Zandvakili, Farnaz; Ebrazeh, Ali; Shokri, Azad; Moradpour, Farhad

doi:10.1186/s12884-024-06492-1

Cited by 3 publications

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Impact of Prenatal COVID-19 Infection on Maternal and Child Health: Early Insights from the PREGCOVID Longitudinal Cohort Study in Gujarat, India

Memon,

Saxena,

Shah

et al. 2024

Preprint

View full text Add to dashboard Cite

Impact of Prenatal COVID-19 Infection on Maternal and Child Health: Early Insights from the PREGCOVID Longitudinal Cohort Study in Gujarat, India

Memon,

Saxena,

Shah

et al. 2024

Preprint

View full text Add to dashboard Cite

COVID-19 in pregnancy: Perinatal outcomes and complications

Akinosoglou,

Schinas,

Papageorgiou

et al. 2024

World J Virol

View full text Add to dashboard Cite

BACKGROUND The risk of severe coronavirus disease 2019 (COVID-19) in pregnant women is elevated. AIM To examine the outcomes of pregnant women with COVID-19 and report perinatal outcomes and complications, while providing a brief review of current literature. METHODS The study included pregnant women presenting from April 2020 to February 2022 to the emergency department (ED) of a tertiary hospital. We retrospectively recorded the maternal and perinatal files, including patient epidemiological and clinical characteristics, laboratory values, outcomes, treatment modalities and associations were explored. RESULTS Among the 60 pregnant women, 25% required hospitalization, all of whom were symptomatic. Preterm delivery occurred in 30% of cases. Ten percent of neonates required admission to the neonatal intensive care unit, and 5% were classified as small for their gestational age. All mothers survived COVID-19 and pregnancy, with 6.6% requiring invasive mechanical ventilation. Preterm delivery rates did not differ between hospitalized and non-hospitalized pregnant women; composite unfavorable perinatal outcomes, including stillbirth, small for gestational age, or neonatal intensive care unit (ICU) admission, did not significantly increase in the cases hospitalized for COVID-19 (P = 0.09). The odds of hospitalization increased 2.3-fold for each day of delayed ED presentation [adj. OR (95%CI: 1.46-3.624), P < 0.001]. Comorbidity status was an independent predictor of hospitalization, albeit with marginal significance [adj. OR = 16.13 (95%CI: 1.021-255.146), P = 0.048]. No independent predictors of adverse fetal outcome (composite) were identified, and eventual hospitalization failed to reach statistical significance by a slight margin (P = 0.054). CONCLUSION Delayed ED presentation and comorbidities increase hospitalization odds. This study highlights the importance of continuous and specific guidance for managing pregnant COVID-19 patients, including timely and appropriate interventions to minimize maternal and perinatal morbidity and mortality.

show abstract

Evaluation of Neonatal and Maternal Outcomes in Pregnant Women with COVID-19 in Southern Iran: A Case-Control Study

Davoodi,

Barzegar,

Bahrami

et al. 2024

Arch Pediatr Infect Dis

View full text Add to dashboard Cite

Background: Pregnant women and their fetuses are considered high-risk populations during pandemics, including coronavirus disease 2019 (COVID-19). Objectives: This study aims to evaluate maternal and neonatal outcomes among pregnant women infected with COVID-19. Methods: This descriptive, analytical, retrospective case-control study included COVID-19-infected pregnant women referred to hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from March 2021 to March 2022. Data were collected using a pre-designed checklist covering demographic information and maternal and neonatal outcomes. Analyses were performed using SPSS version 25, with the significance level set at P < 0.05. Results: Significant differences were observed in maternal and neonatal outcomes for variables such as vaginal bleeding, fetal distress, premature birth, intrauterine death, ICU admission, low birth weight, and NICU admission (P < 0.05). Although neonatal transient tachypnea and pneumonia were more than twice as common in infants of COVID-19-infected mothers compared to controls, these findings were not statistically significant (P > 0.05). Similarly, abnormal lung X-rays, thrombocytopenia, and positive CRP were slightly more frequent in infants born to COVID-19-infected mothers, but these differences did not reach statistical significance (P > 0.05). Conclusions: The study highlights the increased risks of adverse short-term and long-term maternal and neonatal outcomes associated with COVID-19 during pregnancy. Prioritizing pregnancy-specific interventions is crucial in pandemic management to mitigate these risks and improve outcomes for both mothers and their infants.

show abstract

Is the surge in cesarean section rates during the COVID-19 pandemic truly substantiated?

Cited by 3 publications

References 27 publications

Impact of Prenatal COVID-19 Infection on Maternal and Child Health: Early Insights from the PREGCOVID Longitudinal Cohort Study in Gujarat, India

Impact of Prenatal COVID-19 Infection on Maternal and Child Health: Early Insights from the PREGCOVID Longitudinal Cohort Study in Gujarat, India

COVID-19 in pregnancy: Perinatal outcomes and complications

Evaluation of Neonatal and Maternal Outcomes in Pregnant Women with COVID-19 in Southern Iran: A Case-Control Study

Contact Info

Product

Resources

About